Balugrastim
- Generic Name
- Balugrastim
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 527698-09-5
- Unique Ingredient Identifier
- T6K4P3HIU8
- Background
Balugrastim has been used in trials studying the treatment of Solid Tumors.
- Associated Conditions
- -
- Associated Therapies
- -
Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors
- First Posted Date
- 2013-09-12
- Last Posted Date
- 2015-01-14
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Registration Number
- NCT01940601
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath